Skip to main navigation Skip to search Skip to main content

Normal external genitalia in a female with classical congenital adrenal hyperplasia who was not treated during embryogenesis

  • Nada Quercia
  • , David Chitayat
  • , Riyana Babul-Hirji
  • , Maria I. New
  • , Denis Daneman

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Classical congenital adrenal hyperplasia (CAH) results from an inherited enzymatic defect in cortisol synthesis and more than 90 per cent of cases are due to 21-hydroxylase deficiency. The androgen excess associated with this condition typically results in ambiguous external genitalia in affected females. It has been shown that prenatal treatment with dexamethasone is successful in preventing or reducing genital ambiguity in affected females. Rather than treating with dexamethasone, some couples choose to terminate the pregnancy when an affected fetus is prenatally diagnosed. We report a female with classicial CAH who was born with normal external genitalia, although maternal treatment with dexamethasone did not begin until 16 weeks' gestation.

Original languageEnglish
Pages (from-to)83-85
Number of pages3
JournalPrenatal Diagnosis
Volume18
Issue number1
DOIs
StatePublished - Jan 1998
Externally publishedYes

Keywords

  • 21-hydroxylase deficiency
  • Ambiguous genitalia
  • Congenital adrenal hyperplasia
  • Dexamethasone
  • Prenatal diagnosis
  • Prenatal treatment

Fingerprint

Dive into the research topics of 'Normal external genitalia in a female with classical congenital adrenal hyperplasia who was not treated during embryogenesis'. Together they form a unique fingerprint.

Cite this